Indivior PLC(INDV) - 2025 Q4 - Annual Results

Exhibit 99.1 Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results Richmond, VA, February 26, 2026 – Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today reported its financial results for the fourth quarter and full year ended December 31, 2025, and provided a business update. "In 2025 we successfully completed Phase I of the Indivior Action Agenda – Generate Momentum," said Joe Ciaffoni, Chief Executive Officer. "We sharpened our focus on our highest growth opportunity, U.S. SUBLOCADE, estab ...